NCT02413515View on ClinicalTrials.gov

Blood Pressure Control of Nifedipine GITS 60mg Treatment in Chinese Hypertensive Subjects Uncontrolled on Starting-dose Mono-therapyo-therapy.

PHASE4CompletedINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

March 26, 2015

Primary Completion Date

August 8, 2016

Study Completion Date

August 8, 2016

Conditions
Hypertension
Interventions
DRUG

Nifedipine (Adalat GITS, BAY1040)

Nifedipine GITS 60 mg tablet, once daily, oral intake, for 8 weeks treatment

Trial Locations (14)

100028

Beijing

100037

Beijing

200025

Shanghai

210008

Nanjing

300052

Tianjin

310006

Hangzhou

350001

Fuzhou

410008

Changsha

430022

Wudan

710061

Xi’an

063000

Tangshan

Unknown

Beijing

Shandong

Tangshang

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY